Nonfasting Blood Test Can Help Screen Youth for Prediabetes, Diabetes
A study suggests the hemoglobin A1c test can identify youth at high risk of developing type 2 diabetes and associated cardiovascular problems.
Read MorePosted by Melanie Hamilton-Basich | Aug 15, 2020 | Diabetes & Metabolic Diseases |
A study suggests the hemoglobin A1c test can identify youth at high risk of developing type 2 diabetes and associated cardiovascular problems.
Read MorePosted by Melanie Hamilton-Basich | Aug 7, 2020 | Covid 19, Uncategorized |
Elevated levels of these five biomarkers were associated with inflammation and bleeding disorder as well as increased risk of death in covid-19 patients.
Read MorePosted by Laurie Bonner | Jul 4, 2020 | Diabetes & Metabolic Diseases |
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease.
Read MorePosted by | Apr 6, 2020 | Diagnostic Technologies |
The partnership will utilize ProSciento’s NASH Pass patient registry and Nordic Bioscience’s biomarker technology to identify and validate translational biomarkers to improve the diagnosis, prognosis, and development of therapeutics for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).
Read MoreThe researchers examined 1990–2017 data from the Global Burden of Disease Study pertaining to 195 countries and territories.
Read More